INM
Price
$4.51
Change
-$0.68 (-13.10%)
Updated
Dec 18, 03:30 PM (EDT)
TTNP
Price
$3.53
Change
+$0.09 (+2.62%)
Updated
Dec 18, 04:00 PM (EDT)
Ad is loading...

INM vs TTNP

Header iconINM vs TTNP Comparison
Open Charts INM vs TTNPBanner chart's image
InMed Pharmaceuticals
Price$4.51
Change-$0.68 (-13.10%)
Volume$868
CapitalizationN/A
Titan Pharmaceuticals
Price$3.53
Change+$0.09 (+2.62%)
Volume$100
CapitalizationN/A
INM vs TTNP Comparison Chart
Loading...
INM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TTNP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INM vs. TTNP commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INM is a Hold and TTNP is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (INM: $5.19 vs. TTNP: $3.44)
Brand notoriety: INM and TTNP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INM: 9% vs. TTNP: 432%
Market capitalization -- INM: $3.73M vs. TTNP: $3.14M
INM [@Biotechnology] is valued at $3.73M. TTNP’s [@Biotechnology] market capitalization is $3.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INM’s FA Score shows that 0 FA rating(s) are green whileTTNP’s FA Score has 0 green FA rating(s).

  • INM’s FA Score: 0 green, 5 red.
  • TTNP’s FA Score: 0 green, 5 red.
According to our system of comparison, INM is a better buy in the long-term than TTNP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INM’s TA Score shows that 7 TA indicator(s) are bullish while TTNP’s TA Score has 4 bullish TA indicator(s).

  • INM’s TA Score: 7 bullish, 2 bearish.
  • TTNP’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, INM is a better buy in the short-term than TTNP.

Price Growth

INM (@Biotechnology) experienced а +2.27% price change this week, while TTNP (@Biotechnology) price change was -5.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +1.43%, and the average quarterly price growth was +4.23%.

Reported Earning Dates

INM is expected to report earnings on Nov 14, 2024.

TTNP is expected to report earnings on Feb 28, 2024.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INM($3.73M) has a higher market cap than TTNP($3.15M). INM YTD gains are higher at: -37.620 vs. TTNP (-58.303). INM has higher annual earnings (EBITDA): -6.66M vs. TTNP (-7.09M). INM has more cash in the bank: 5.58M vs. TTNP (4.09M). TTNP has less debt than INM: TTNP (0) vs INM (1.06M). INM has higher revenues than TTNP: INM (4.96M) vs TTNP (0).
INMTTNPINM / TTNP
Capitalization3.73M3.15M119%
EBITDA-6.66M-7.09M94%
Gain YTD-37.620-58.30365%
P/E Ratio0.02N/A-
Revenue4.96M0-
Total Cash5.58M4.09M136%
Total Debt1.06M0-
FUNDAMENTALS RATINGS
INM vs TTNP: Fundamental Ratings
INM
TTNP
OUTLOOK RATING
1..100
2265
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
100
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
5090
P/E GROWTH RATING
1..100
10082
SEASONALITY SCORE
1..100
8585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INM's Valuation (43) in the null industry is somewhat better than the same rating for TTNP (100) in the Pharmaceuticals Major industry. This means that INM’s stock grew somewhat faster than TTNP’s over the last 12 months.

INM's Profit vs Risk Rating (100) in the null industry is in the same range as TTNP (100) in the Pharmaceuticals Major industry. This means that INM’s stock grew similarly to TTNP’s over the last 12 months.

INM's SMR Rating (98) in the null industry is in the same range as TTNP (100) in the Pharmaceuticals Major industry. This means that INM’s stock grew similarly to TTNP’s over the last 12 months.

INM's Price Growth Rating (50) in the null industry is somewhat better than the same rating for TTNP (90) in the Pharmaceuticals Major industry. This means that INM’s stock grew somewhat faster than TTNP’s over the last 12 months.

TTNP's P/E Growth Rating (82) in the Pharmaceuticals Major industry is in the same range as INM (100) in the null industry. This means that TTNP’s stock grew similarly to INM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INMTTNP
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
86%
Bullish Trend 23 days ago
79%
Declines
ODDS (%)
Bearish Trend 20 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
INM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TTNP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SCNI3.480.03
+1.00%
Scinai Immunotherapeutics Ltd.
OFIX17.93-0.08
-0.44%
Orthofix Medical
ALV94.34-0.84
-0.88%
Autoliv
DLNG4.40-0.07
-1.57%
Dynagas LNG Parners LP
PPBI26.57-0.94
-3.42%
Pacific Premier Bancorp

INM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INM has been loosely correlated with TFFP. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if INM jumps, then TFFP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INM
1D Price
Change %
INM100%
N/A
TFFP - INM
53%
Loosely correlated
N/A
TTNP - INM
46%
Loosely correlated
+1.47%
EYEN - INM
39%
Loosely correlated
+7.84%
OMER - INM
36%
Loosely correlated
+3.82%
MTEM - INM
31%
Poorly correlated
-2.44%
More

TTNP and

Correlation & Price change

A.I.dvisor indicates that over the last year, TTNP has been loosely correlated with INM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if TTNP jumps, then INM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TTNP
1D Price
Change %
TTNP100%
+1.47%
INM - TTNP
46%
Loosely correlated
N/A
ORMP - TTNP
28%
Poorly correlated
-1.67%
SPHRY - TTNP
27%
Poorly correlated
+8.81%
CDTX - TTNP
27%
Poorly correlated
-1.93%
RVPH - TTNP
26%
Poorly correlated
-39.13%
More